Bibliografia UJ CM

1/9
Meletios A. Dimopoulos, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Bjorn E. Wahlin, Ramon Garcia-Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Steven P. Treon, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S. Tam.
Zanubrutinib versus ibrutinib in symptomatic Waldenström macroglobulinemia : final analysis from the randomized phase III ASPEN study
Journal of Clinical Oncology
2023, il., bibliogr. 16 poz., abstr.
Autor korespondencyjny: Meletios A. Dimopoulos
Online First 2023-07-21
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
2/9
Michael L. Wang, Wojciech Jurczak, Mats Jerkeman, Judith Trotman, Pier L. Zinzani, David Belada, Carola Boccomini, Ian W. Flinn, Pratyush Giri, Andre Goy, Paul A. Hamlin, Olivier Hermine, José-Ángel Hernández-Riva, Xiaonan Hong, Seok Jin Kim, David Lewis, F.R.C. Path, Yuko Mishima, Muhit Özcan, Guilherme F. Perini, Christopher Pocock, Yuqin Song, Stephen E. Spurgeon, John M. Storring, Jan Walewski, Jun Zhu, Rui Qin, Todd Henninger, Sanjay Deshpande, Angela Howes, Steven Le Gouill, Martin Dreyling.
Ibrutinib plus bendamustine and rituximab in untreated mantle-cell lymphoma
New England Journal of Medicine
2022 : Vol. 386, nr 26, s. 2482-2494, il., bibliogr. 24 poz., abstr.
Autor korespondencyjny: Michael L. Wang.
p-ISSN: 0028-4793
e-ISSN: 1533-4406
AZ
ORG
AIF
IF: 158.500
Adres url:
Streszczenie w PubMed:
3/9
Grzegorz S. Nowakowski, Annalisa Chiappella, Randy D. Gascoyne, David W. Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Ozcan, Xiaonan Hong, Jun Zhu, Jie Jin, David Belada, Juan Miguel Bergua, Francesco Piazza, Heidi Mocikova, Anna Lia Molinari, Dok Hyun Yoon, Federica Cavallo, Monica Tani, Kazuhito Yamamoto, Koji Izutsu, Koji Kato, Myron Czuczman, Sarah Hersey, Adrian Kilcoyne, Jacqueline Russo, Krista Hudak, Jingshan Zhang, Steve Wade, Thomas E. Witzig, Umberto Vitolo.
ROBUST : A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Journal of Clinical Oncology
2021 : Vol. 39, nr 12, s. 1317-1328, il., bibliog. 38 poz., abstr.
Autor korespondencyjny: Grzegorz S. Nowakowski.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
4/9
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton Marlton, Björn E. Wahlin, Ramon Garcia Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, Meletios Dimopoulos.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia : the ASPEN study.
Blood
2020 : Vol. 136, nr 18, s. 2038-2050, il., bibliogr. 39 poz., abstr.
Auto korespondencyjny: Constantine S. Tam.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 22.113
Adres url:
Streszczenie w PubMed:
5/9
Ruth Pettengell, Monika Długosz-Danecka, David Andorsky, David Belada, Pencho Georgiev, Donald Quick, Jack W. Singer, Simran B. Singh, Athanasios Pallis, Anton Egorov, Gilles Salles.
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).
British Journal of Haematology
2020 : Vol. 188, nr 2, s. 240-248, il., bibliogr. sum.
Autor korespondencyjny: Ruth Pettengell.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 6.998
Adres url:
Streszczenie w PubMed:
6/9
Anas Younes, Laurie H. Sehn, Peter Johnson, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh, Sirpa Leppa, Shinya Rai, Mehmet Turgut, Wojciech Jurczak, Matthew C. Cheung, Ronit Gurion, Su-Peng Yeh, Andres Lopez-Hernandez, Ulrich Duhrsen, Catherine Thieblemont, Carlos Sergio Chiattone, Sriram Balasubramanian, Jodi Carey, Grace Liu, Martin Shreeve, Steven Sun, Sen Hong Zhuang, Jessica Vermeulen, Louis M. Staudt, Wyndham Wilson.
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Journal of Clinical Oncology
2019 : Vol. 37, nr 15, s. 1285-1295, bibliogr., abstr.
Autor korespondencyjny: Anas Younes.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 32.956
Adres url:
Streszczenie w PubMed:
7/9
Luca Arcaini, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Jose Cabecadas, Elias Campo, Stefano A. Pileri, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Marek Trneny.
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma
British Journal of Haematology
2018 : Vol. 180, nr 2, s. 224-235, il., bibliogr., sum.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
Autor korespondencyjny: Luca Arcaini.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 5.206
Adres url:
Streszczenie w PubMed:
8/9
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Boris Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Casadebaig Bravo, Luca Arcaini.
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Lancet. Oncology
2016 : Vol. 17, nr 3, s. 319-331, il., bibliogr. 28 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
9/9
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John A. Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon A. Rule, Boris V. Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Evelyn Barnett, Marie-Laure Casadebaig Bravo, Luca Arcaini.
Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup Analysis of the SPRINT (MCL-002) Trial.
Blood
2016 : Vol. 128, nr 22, s. 2978
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ